3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
6
Recruiting
3
Terminated
2
Not yet recruiting
2
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Conditions
Breast Neoplasms
9
Rectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Squamous Cell Carcinoma of Head and Neck
6
Uterine Cervical Neoplasms
4
Small Cell Lung Carcinoma
4
Prostatic Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Glioblastoma
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Neoplasms
3
Nasopharyngeal Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma
2
Spinal Cord Neoplasms
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Cancer Patients
1
Radiation Injuries
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pelvic Neoplasms
1
Interventions
Oxaliplatin
4
Capecitabine
3
Radiotherapy
2
Docetaxel
2
Androgen Antagonists
2
tislelizumab
1
pembrolizumab
1
luprolide acetate gel depot
1
lenvatinib
1
enzalutamide
1
cemiplimab
1
Surgical Procedures, Operative
1
Radiotherapy, Image-Guided
1
Poly(ADP-ribose) Polymerase Inhibitors
1
PF06821497
1
Negative-Pressure Wound Therapy
1
Leuprolide
1
Leucovorin
1
Injections
1
Fluorouracil
1
Drug Therapy
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma
×
Radiotherapy
×
Clear all
NCT07118800
2025-08-12
NACRE-2
UNICANCER
Phase 3
Not yet recruiting
160 enrolled
NCT06855589
2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3
Not yet recruiting
400 enrolled